~~<i id='B4DE73271C'><strike id='B4DE73271C'><tt id='B4DE73271C'><pre id='B4DE73271C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

knowledge

author：leisure time 2025-09-30 21:07:31 - browse：92782

AP/Richard Drew

Johnson & Johnson said Monday that it would purchase Ambrx Biopharma for nearly $2 billion, picking up a company specializing in targeted chemotherapy treatments — one of the hottest areas of cancer drug development.

The deal, disclosed as the biopharma field marked the first day of the annual J.P. Morgan Healthcare Conference, extends a recent spate of pharma acquisitions, contributing to hopes that 2024 could be a better year for the industry.

Under the agreement, J&J will pay $28 per share in cash for Ambrx, roughly a 100% premium to the latter’s recent trading price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Providers still hesitate to prescribe buprenorphine, study finds

focus

knowledge

focus

leisure time

explore

entertainment

3:16FILE-CardinalMatteoZuppi,headoftheCEI(ItalianConferenceofBishops),welcomesparishionersafterceleb

WSS

Review: 'Barbie' will hit you like a shot in the heart

HIPAA doesn't protect reproductive records from prosecutors

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Regeneron agrees to White House price limits on anti

HIPAA doesn't protect reproductive records from prosecutors

leisure time

knowledge

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What to make of Biden’s latest efforts on cancer research

Drug repurposing or repositioning? The language matters

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

BioMarin wins approval for gene therapy to treat hemophilia A

Death toll from an explosion and collapse of a Paris building in June climbs to 3

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

PEPFAR is under serious threat — and so is global health

Apple is now the first public company to be valued at $3 trillion

Will.i.am, Britney Spears release new single, 'Mind Your Business'

knowledge

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Organ transplantation is at a crossroads. Major reform is needed

Review: 'Barbie' will hit you like a shot in the heart

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Elizabeth Warren probes abortion access

focus

leisure time

explore

entertainment